| 1 |
Tumor necrosis factor-a gene promoter -308 and -238 polymorphisms and its serum level in psoriasis |
|
|
| Magda M. Hagag, Mai M. Ghazy, Nesreen G. Elhelbawy |
|
| Biochemistry and Biophysics Reports. 2021; 27: 101050 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Polymorphisms in the TNF-a and IL-10 gene promoters and risk of psoriasis and correlation with disease severity |
|
|
| Rehab A Karam,Haidy E Zidan,Mohamed Hamed Khater |
|
| Cytokine. 2014; 66(2): 101 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Document Polymorphisms in the TNF-α and IL-10 gene promoters and risk of psoriasis and correlation with disease severity |
|
|
| Karam, R.A., Zidan, H.E., Khater, M.H. |
|
| Cytokine. 2014; |
|
| [Pubmed] [Google Scholar] |
|
| 4 |
TNFAIP3 and IL12B gene polymorphisms associated with psoriasis vulgaris in an Egyptian cohort. |
|
|
| O. Haase,H. Mosaad,M.A. Eldarouti,A.Z. Elramly,N. Samir,M.M. Abdelhady,M. Samir,I. El-Gharib,S. Salah,F.A. El-Shennawy,Y. Mosaad,N. Elwan,H. Salem,S. Abdelgaber,A. Recke,S. Möller,D. Zillikens,S. Ibrahim |
|
| Journal of the European Academy of Dermatology and Venereology. 2014; : n/a |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Genetic variations in IL6 and IL12B decreasing the risk for psoriasis |
|
|
| Andreea Nicoleta Boca,Marina Talamonti,Marco Galluzzo,Elisabetta Botti,Stefan Cristian Vesa,Sergio Chimenti,Anca Dana Buzoianu,Antonio Costanzo |
|
| Immunology Letters. 2013; 156(1-2): 127 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Cepharanthine: A Therapeutic Potential Candidate for Psoriasis |
|
|
| Nader Pazyar,Noorodin Jamshydian |
|
| The Journal of Alternative and Complementary Medicine. 2012; 18(7): 639 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
